Want to see JP:9438 full AI Analyst Report?
Top Page
MTI Ltd.
(9438)
Select Model
Select Model
Rating:73Outperform
Price Target:
¥629.00
▼(-12.76% Downside)
Action:Reiterated
Date:08/07/26
The score is driven primarily by strong financial performance (high margins, low leverage, and solid cash generation) and supportive valuation (low P/E and meaningful dividend yield). These positives are partially offset by weak technical positioning, with the stock trading below major moving averages and showing soft near-term momentum.
Positive Factors
High Profitability
Sustained high gross and healthy net margins indicate durable pricing power and a capital-light business mix typical of healthcare information services. These margins support sustained internal funding for R&D, dividends and resilience to cost shocks, underpinning long-term cash generation.
Negative Factors
Slowing Revenue Growth
A marked slowdown in top-line growth limits the leverage of strong margins and constrains scale economies. If persistent, it forces reliance on margin expansion or buybacks to drive returns, and suggests the company may face market saturation or intensifying competition for durable expansion.
Read all positive and negative factors
Positive Factors
Negative Factors
High Profitability
Sustained high gross and healthy net margins indicate durable pricing power and a capital-light business mix typical of healthcare information services. These margins support sustained internal funding for R&D, dividends and resilience to cost shocks, underpinning long-term cash generation.
Read all positive factors
MTI Ltd. (9438) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥31.88B
Dividend Yield3.31%
Average Volume (3M)62.04K
Price to Earnings (P/E)9.4
Beta (1Y)0.41
Revenue Growth4.90%
EPS Growth60.31%
CountryJP
Employees1,236
SectorGeneral
Sector StrengthN/A
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)63.51
Shares Outstanding60,435,200
10 Day Avg. Volume33,460
30 Day Avg. Volume62,043
Financial Highlights & Ratios
PEG Ratio0.29
Price to Book (P/B)2.31
Price to Sales (P/S)1.42
P/FCF Ratio7.62
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)39.6
Revenue Forecast (FY)¥30.40B
MTI Ltd. Business Overview & Revenue Model
Company Description
Established in Tokyo, Japan, in 1996, MTI Ltd. is a prominent provider of mobile content solutions across the nation. The company delivers a diverse portfolio of digital services designed for various user needs. These include Boshimo, an applicati...
MTI Ltd. Financial Statement Overview
Summary
Income Statement
82
Very Positive
Balance Sheet
78
Positive
Cash Flow
75
Positive
| Breakdown | TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 30.88B | 29.91B | 27.67B | 26.80B | 26.48B | 25.74B |
| Gross Profit | 22.63B | 22.22B | 20.40B | 18.37B | 18.69B | 18.74B |
| EBITDA | 5.22B | 6.02B | 5.17B | 2.91B | 1.44B | 2.45B |
| Net Income | 3.52B | 3.40B | 2.36B | 753.22M | -930.48M | -1.16B |
Balance Sheet | ||||||
| Total Assets | 33.45B | 33.35B | 29.70B | 29.17B | 29.28B | 31.91B |
| Cash, Cash Equivalents and Short-Term Investments | 16.12B | 17.82B | 14.83B | 13.72B | 12.10B | 15.54B |
| Total Debt | 1.14B | 1.69B | 2.43B | 3.18B | 3.93B | 2.88B |
| Total Liabilities | 10.25B | 10.90B | 10.55B | 11.58B | 11.40B | 10.67B |
| Stockholders Equity | 19.61B | 18.41B | 15.47B | 14.01B | 14.18B | 17.59B |
Cash Flow | ||||||
| Free Cash Flow | 5.58B | 5.58B | 2.74B | 3.60B | -3.59B | 1.74B |
| Operating Cash Flow | 5.66B | 5.66B | 4.13B | 4.76B | -1.39B | 3.52B |
| Investing Cash Flow | -1.02B | -1.02B | -1.37B | -1.35B | -2.46B | -2.00B |
| Financing Cash Flow | -1.63B | -1.63B | -1.64B | -1.78B | 343.54M | 649.18M |
MTI Ltd. Technical Analysis
Positive
721.00
Price Trends
584.04
Positive
593.35
Positive
656.26
Negative
Market Momentum
-2.07
Positive
54.04
Neutral
74.07
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9438, the sentiment is Positive. The current price of 721 is above the 20-day moving average (MA) of 601.10, above the 50-day MA of 584.04, and above the 200-day MA of 656.26, indicating a neutral trend. The MACD of -2.07 indicates Positive momentum. The RSI at 54.04 is Neutral, neither overbought nor oversold. The STOCH value of 74.07 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:9438.
MTI Ltd. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥31.88B | 9.40 | ― | 2.58% | 4.90% | 60.31% | |
65 Neutral | ¥1.18T | 25.22 | 12.38% | 1.16% | 15.76% | 13.53% | |
63 Neutral | ¥220.55B | 31.82 | ― | 0.43% | 18.89% | 11.66% | |
59 Neutral | ¥91.99B | 46.74 | 6.35% | ― | 24.03% | 34.50% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
37 Underperform | ¥2.24B | -4.24 | ― | ― | 14.84% | 30.67% |
* General Sector Average
JP:9438
MTI Ltd.
605.00
-186.58
-23.57%
JP:2413
M3
1,695.50
-606.86
-26.36%
JP:4480
Medley
2,844.00
7.00
0.25%
JP:4438
Welby Inc.
259.00
-71.00
-21.52%
JP:4483
JMDC Inc.
3,425.00
-854.18
-19.96%
MTI Ltd. Corporate Events
MTI Books Tax Windfall, Trims Earnings Outlook on Healthcare Investments
Aug 6, 2026
MTI Ltd. will record approximately 524 million yen in extraordinary income in the fourth quarter of the fiscal year ending September 30, 2026, after receiving a tax refund related to the consumption tax treatment of expired points in its point-bas...
MTI Posts Higher Sales and Profit but Flags Weaker Full-Year Outlook
Aug 6, 2026
MTI Ltd. reported a 4.4% year-on-year increase in net sales to ¥23.28 billion for the first three quarters of the fiscal year ending September 30, 2026, with ordinary income rising 18.6% and profit attributable to owners of the parent up 5.6%...
MTI Restructures Pharmacy DX Subsidiaries, Books Extraordinary Income
Jul 17, 2026
MTI Ltd. has resolved to transfer all shares of its consolidated subsidiary Eagle Inc., a provider of cloud-based business systems for dispensing pharmacies, to fellow subsidiary MTI Healthcare Holdings Inc. Eagle’s solutions aim to streamli...
MTI Reshapes Executive Team to Tighten Control of Core Divisions
Jun 19, 2026
MTI Ltd. has announced changes to its executive lineup, effective July 1, 2026, following a June 19 board meeting. The moves concentrate leadership over key sales and technology functions, signaling a tightening of operational control across its c...
MTI Sets FY2026 Strategy Around Healthcare and School DX Growth
May 13, 2026
MTI Ltd. released materials for its Q2 FY2026 financial results briefing, outlining consolidated profit and loss, SGA trends, balance sheet data, segment performance, and a revised full-year earnings forecast. Management also detailed basic polici...
MTI Posts Higher H1 Earnings but Signals Full-Year Profit Decline
May 12, 2026
MTI Ltd. reported consolidated net sales of ¥15.67 billion for the first half of the fiscal year ending September 30, 2026, up 5.2% year on year, with operating income rising slightly to ¥1.68 billion and ordinary income climbing nearly ...
MTI Maintains 10 Yen Interim Dividend Despite Strong First-Half Results
May 12, 2026
MTI Ltd. has declared an interim dividend of 10 yen per share, with March 31, 2026 as the record date, maintaining the payout level in line with its stable dividend policy. The total cash distribution will amount to 557 million yen, up from 499 mi...
MTI Raises Earnings Forecasts on Healthcare and DX Growth
May 8, 2026
MTI Ltd. has sharply upgraded its earnings outlook for the first half of the fiscal year ending September 30, 2026, citing stronger-than-expected revenue growth in its healthcare and corporate DX support businesses. The company now forecasts highe...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.